SLIDE 1
Disclaimer
Important information This presentation has been prepared by Calliditas Therapeutics AB (“Calliditas” or the “Company”) for informational purposes only and not for any other
- purpose. Nothing contained in this presentation is, or should be construed as, a recommendation, promise or representation by the presenter or the
company or any director, employee, agent, or adviser of the company. This presentation does not purport to be all-inclusive or to contain all of the information you may desire. This presentation also contains estimates and other statistical data made by independent parties and by us relating to market size and growth and other data about our industry. This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. This presentation contains various forward-looking statements that reflect the Company’s current views with respect to future events and financial and
- perational performance. The words “believe,” “expect,” “anticipate,” “intend,” “may,” “plan,” “estimate,” “should,” “could,” “aim,” “target,” “might,” or, in
each case, their negative, or similar expressions identify certain of these forward-looking statements. Others can be identified from the context in which the statements are made. These forward-looking statements involve known and unknown risks, uncertainties and other factors, which are in some cases beyond the Company’s control and may cause actual results, development or performance to differ materially from those expressed or implied from such forward-looking statements. The information and opinions contained in this document are provided as at the date of this presentation and are subject to change without notice, and neither the Company nor any other person are under any obligation to update the presentation, except as provided for in applicable laws and/or stock exchange regulations. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed
- n, the fairness, accuracy or completeness of the information contained herein. The reader should not place undue reliance on any forward-looking
statements included in this presentation. Except as explicitly stated herein, no information in this document has been audited or reviewed by Calliditas’
- auditors. These statements speak only as of the date made and Calliditas is under no obligation and disavows any obligation to update or revise such
statements as a result of any event, circumstances or otherwise, unless required by applicable legislation.
February 20 Corporate Presentation
2